Lotan Y - Search Results

1

Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN. Soria F, et al. Among authors: lotan y. World J Urol. 2017 Mar;35(3):379-387. doi: 10.1007/s00345-016-1928-x. Epub 2016 Sep 7. World J Urol. 2017. PMID: 27604375 Free article. Review.

2

Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.

Lotan Y, Roehrborn CG. Lotan Y, et al. J Urol. 2002 Jan;167(1):75-9. J Urol. 2002. PMID: 11743279

3

Cost-effective treatment for ureteropelvic junction obstruction: a decision tree analysis.

Gettman M, Lotan Y, Roerhborn CG, Cadeddu JA, Pearle MS. Gettman M, et al. Among authors: lotan y. J Urol. 2003 Jan;169(1):228-32. doi: 10.1016/S0022-5347(05)64074-8. J Urol. 2003. PMID: 12478142

4

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

Lotan Y, Roehrborn CG. Lotan Y, et al. Urology. 2003 Jan;61(1):109-18; discussion 118. doi: 10.1016/s0090-4295(02)02136-2. Urology. 2003. PMID: 12559279 Review.

5

Histopathology of surgically managed renal tumors: analysis of a contemporary series.

Duchene DA, Lotan Y, Cadeddu JA, Sagalowsky AI, Koeneman KS. Duchene DA, et al. Among authors: lotan y. Urology. 2003 Nov;62(5):827-30. doi: 10.1016/s0090-4295(03)00658-7. Urology. 2003. PMID: 14624902 Review.

6

The effects of radio frequency ablation on renal function and blood pressure.

Johnson DB, Taylor GD, Lotan Y, Sagalowsky AI, Koenemann KS, Cadeddu JA. Johnson DB, et al. Among authors: lotan y. J Urol. 2003 Dec;170(6 Pt 1):2234-6. doi: 10.1097/01.ju.0000096265.22657.e8. J Urol. 2003. PMID: 14634386

7

Survivin expression is associated with features of biologically aggressive prostate carcinoma.

Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM, Ashfaq R. Shariat SF, et al. Among authors: lotan y. Cancer. 2004 Feb 15;100(4):751-7. doi: 10.1002/cncr.20039. Cancer. 2004. PMID: 14770431 Free article.

8

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

9

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.

Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS. Khoddami SM, et al. Among authors: lotan y. BJU Int. 2004 Jul;94(1):42-6. doi: 10.1111/j.1464-410X.2004.04898.x. BJU Int. 2004. PMID: 15217428

10

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.

Shariat SF, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Sawczuk I, Serretta V, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Wians F Jr, Roehrborn CG, Lotan Y, Perrotte P, Benayoun S, Marberger MJ, Karakiewicz PI. Shariat SF, et al. Among authors: lotan y. J Urol. 2005 May;173(5):1518-25. doi: 10.1097/01.ju.0000154696.48217.75. J Urol. 2005. PMID: 15821471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

743 results

Search Page